Chen Yingqi, Mu Shanshan, Wang Jing, Wu Anshi
Department of Anesthesiology, Beijing Chao-Yang Hospital, Beijing, China.
Ann Transl Med. 2020 Dec;8(24):1663. doi: 10.21037/atm-20-7680.
Orthotopic liver transplantation (OLT) offers the highest chance of cure in comparison with all other treatment for liver tumors and other end stage liver disease. However, the complications caused by liver transplantation significantly affect its therapeutic effect, and acute kidney injury (AKI) is one of the most common of these. It is, therefore, necessary to identify the risk factors of AKI after liver transplantation.
A single-center, retrospective study of patients receiving liver transplantation at the Beijing Chao-Yang Hospital between January 2015 to January 2019 was conducted.Patients were divided into a normal control group and AKI group based on their previous medical history. Preoperative and intraoperative indicators including preoperative creatinine, uric acid, and the intraoperative input of protein were then recorded.
A total of 419 patients were enrolled into the study. The control group consisted of 336 patients while 83 patients formed an AKI group based on the grading criteria of AKI. There were significant differences in chronic severe hepatitis (P=0.001), liver cancer (P=0.044), intraoperative input of sodium bicarbonate (P=0.019), input of red blood cell suspension (P=0.004), the input of blood plasma (P=0.043), intraoperative urine output (P=0.006), and preoperative creatinine (P=0.041) between the control and AKI group. Multivariate analysis indicated that chronic severe hepatitis (OR: 2.872; P=0.003) and preoperative creatinine (OR: 1.083; P=0.011) were independent risk factors for AKI in patients receiving liver transplantation.
Chronic severe hepatitis and preoperative creatinine may be potential risk factors for the occurrence of AKI after liver transplantation.
与肝肿瘤及其他终末期肝病的所有其他治疗方法相比,原位肝移植(OLT)提供了最高的治愈机会。然而,肝移植引起的并发症显著影响其治疗效果,急性肾损伤(AKI)是其中最常见的并发症之一。因此,有必要确定肝移植后AKI的危险因素。
对2015年1月至2019年1月在北京朝阳医院接受肝移植的患者进行单中心回顾性研究。根据患者既往病史将其分为正常对照组和AKI组。然后记录术前和术中指标,包括术前肌酐、尿酸以及术中蛋白质输入量。
共纳入419例患者进行研究。根据AKI分级标准,对照组有336例患者,83例患者组成AKI组。对照组和AKI组在慢性重型肝炎(P = 0.001)、肝癌(P = 0.044)、术中碳酸氢钠输入量(P = 0.019)、红细胞悬液输入量(P = 0.004)、血浆输入量(P = 0.043)、术中尿量(P = 0.006)和术前肌酐(P = 0.041)方面存在显著差异。多因素分析表明,慢性重型肝炎(OR:2.872;P = 0.003)和术前肌酐(OR:1.083;P = 0.011)是肝移植患者发生AKI的独立危险因素。
慢性重型肝炎和术前肌酐可能是肝移植后发生AKI的潜在危险因素。